Title:
【発明の名称】テトラックの薬学組成物およびその使用方法
Document Type and Number:
Japanese Patent JP2002542284
Kind Code:
A
Abstract:
The present invention provides novel pharmaceutical compositions and methods of treatment that utilize or comprise tetrac and/or another thyromimetic compound. The parmaceutical compositions of the invention are capable of suppressing TSH secretion without inhibiting the pituitary specific monodeiodinase type II and while reducing or avoiding the thyromimetic stimulation of peripheral tissues compared to equivalent TSH-suppressive doses of L-thyroxine (T4). The pharmaceutical compositions of the invention are particularly useful for treating patients suffering from malignancy or abnormal growth of the thyroid and for preventing growth of residual thyroid tissue post thyroidectomy.
More Like This:
Inventors:
Danforth, Elliott, Junior
Albert, Burger
Albert, Burger
Application Number:
JP2000613422A
Publication Date:
December 10, 2002
Filing Date:
April 25, 2000
Export Citation:
Assignee:
Danforth, Elliott, Junior
Albert, Burger
Albert, Burger
International Classes:
A61P5/14; A61K31/192; A61K31/195; A61K31/198; A61P5/16; A61P35/00; (IPC1-7): A61K31/192; A61K31/198; A61P5/14; A61P5/16; A61P35/00
Domestic Patent References:
| JPH05255081A | 1993-10-05 |
Attorney, Agent or Firm:
Kenzo Hara (3 outside)